The US Food and Drug Administration (FDA) has rejected a marketing application for Mylan NV's biosimilar version of Amgen Inc's Neulasta (pegfilgrastim), its chemotherapy drug, according to a statement by Biocon Ltd, its Indian partner,...
Enter the keyword(s) you would like to search for within this report:
EIU Country Analysis—The Economist Intelligence Unit, a division of London's Economist Group, is the most respected provider of country analysis for governments, multi-national corporations and financial institutions around the world. Through our network of over 500 international contributor economists, we establish independent macro-economic outlooks and detailed reports on the political and commercial environments for over 200 countries around the world.
Any questions about the report you're considering?
Our Customer Service Team can help! Or visit our FAQs.
Search all our
from one place.